FDA Import Refusal SCS-6981809-6/61/1 — GLAXOSMITHKLINE PHARMACEUTICALSLTD
The FDA refused shipment SCS-6981809-6/61/1 from GLAXOSMITHKLINE PHARMACEUTICALSLTD (India) on Aug 26, 2021. The refused product falls under Drugs and Biologics — ALBENDAZOLE (ANTHELMINTIC). Cited charge: 75 This firm has 5 or more other import refusals on record.
Refusal Details
- Date
- Aug 26, 2021
- Country
- India
- Product Category
- Drugs and Biologics
- Product Code
- 60WCA01 ALBENDAZOLE (ANTHELMINTIC)
- Charges
- 75